EU Cancer Research Collaboration Award 2022

On this page:

Introduction

The purpose of the Irish Cancer Society’s EU Cancer Research Collaboration Award is to support excellent Irish-based cancer researchers in all disciplines to foster and build research and innovation consortia across Europe, through international mobility.

A key aim of this award is to stimulate and promote participation of Ireland’s cancer researchers in future large-scale EU funding schemes through collaboration and sustainable partnerships with academic or non-academic partners. Such schemes may include Horizon Europe, Innovative Medicines Initiative, EU4Health, Digital Europe and Marie Skłodowska-Curie Actions etc. as identified on the EU Funding and Tenders Portal.

Applicants can apply for funding of a maximum €10,000, however this must be appropriately justified based on the duration of mobility proposed.

Each period of mobility is expected to be a minimum of 1 month in duration; there can be more than one period of mobility. Each applicant may only submit one application.

Please see the guidelines for applicants for eligibility criteria.

Funding

The maximum total funding available is €10,000, and must be appropriately justified. Please note that this award can provide funding for a variety of mobility-associated expenses, such as travel, accommodation and consumables while on mobility.

Submission and key dates

Applications must be completed and submitted through the Irish Cancer Society Gateway Grant Tracker online system.

In order to submit an online application you are required to register at the following address: https://grants.cancer.ie

Deadline for applications: 3.00pm, Thursday 8th September 2022

Key Dates

Please note: that the above dates are provisional subject to change at the discretion of the Irish Cancer Society.